Prevalence of mupirocin resistance in Staphylococcus pseudintermedius

J Clin Microbiol. 2014 Apr;52(4):1250-2. doi: 10.1128/JCM.03618-13. Epub 2014 Jan 29.

Abstract

In the United States, veterinary use of mupirocin is primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus pseudintermedius (MRSP). In this study, only 1 of 581 S. pseudintermedius isolates tested was resistant to mupirocin and carried the high-level mupirocin resistance gene, ileS2, on a plasmid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • DNA, Bacterial / chemistry
  • DNA, Bacterial / genetics
  • Dogs
  • Drug Resistance, Bacterial*
  • Genes, Bacterial
  • Molecular Sequence Data
  • Mupirocin / pharmacology*
  • Polymerase Chain Reaction
  • Prevalence
  • Pyoderma / microbiology
  • Pyoderma / veterinary
  • Sequence Analysis, DNA
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / veterinary
  • Staphylococcus / drug effects*
  • Staphylococcus / genetics
  • Staphylococcus / isolation & purification
  • United States

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Mupirocin

Associated data

  • GENBANK/KJ000544
  • GENBANK/KJ000545
  • GENBANK/KJ000546
  • GENBANK/KJ000547
  • RefSeq/NG_041749